Literature DB >> 7779345

Psychotropic drugs in group homes: prevalence and relation to demographic/psychiatric variables.

M G Aman1, G Sarphare, W H Burrow.   

Abstract

All 1,101 clients residing in over 120 group homes of a residential services agency were surveyed on one date for presence of psychotropic medication. In all, 27% received one or more psychotropic drugs for behavioral or emotional disorders. Disorders and target behaviors listed for each drug group were examined and the relations between drug groups and diagnostic/demographic variables analyzed. In addition, logistic regression analyses were used to examine subject variable/drug relations further and the likelihood of receiving a specific class of medication given the presence of a subject variable. Certain physical and sensory handicaps were associated with less medication use. Generally speaking, the existence of DSM diagnoses (especially psychosis and mood disorder) and certain target behaviors were associated with greater medication use. In the main, medication use was consistent with known or presumptive indications for the respective drug groups, although unestablished applications were also observed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779345

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  4 in total

1.  Behaviour management problems as predictors of psychotropic medication and use of psychiatric services in adults with autism.

Authors:  Elias Tsakanikos; Helen Costello; Geraldine Holt; Peter Sturmey; Nick Bouras
Journal:  J Autism Dev Disord       Date:  2007-07

2.  Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio.

Authors:  Michael G Aman; Kristen S L Lam; Angie Collier-Crespin
Journal:  J Autism Dev Disord       Date:  2003-10

3.  Brief report: clonazepam behavioral side effects with an individual with mental retardation.

Authors:  John E Kalachnik; Thomas E Hanzel; Robert Sevenich; Stuart R Harder
Journal:  J Autism Dev Disord       Date:  2003-06

Review 4.  Clozapine for psychotic disorders in adults with intellectual disabilities.

Authors:  Muhammad Ayub; Khalid Saeed; Tariq A Munshi; Farooq Naeem
Journal:  Cochrane Database Syst Rev       Date:  2015-09-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.